← All stocks

Avantor, Inc.

AVTR No buying or selling
CIK 0001722482 #954 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

24 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Stubblefield Michael
President & CEO
1,764,513
$14.68M
+8.0%
Ligner Emmanuel
President and CEO
737,334
$6.13M
MEHRA SANJEEV K
Director
508,376
$4.23M
SUMME GREGORY L
Director
483,381
$4.02M
+1,079%
Jones R. Brent
EVP, Chief Financial Officer
419,782
$3.49M
+1,402%
Walker Corey
President, VWR Dist. & Servs.
384,535
$3.20M
+440.6%
Gourdier Benoit
EVP, Bioscience & Medtech
362,859
$3.02M
+754.7%
Blenn Mary
EVP, Chief Operating Officer
253,384
$2.11M
Sokenu Claudius
EVP, Chief Legal & Compliance
251,228
$2.09M
+544.9%
Hankamer Brittany
EVP, Chief HR Officer
248,864
$2.07M
+615.4%
Peacock Jonathan M
Director
219,815
$1.83M
+12.9%
Couturier Christophe
EVP, AMEA
211,271
$1.76M
+179.8%
Brellier Ludovic
EVP, Bioscience & Medtech
146,566
$1.22M
Eck Steven W
SVP & Chief Accounting Officer
129,593
$1.08M
+338.6%
LUCIER GREGORY T
Director
94,006
$782.13K
Bramwell James
EVP Sales, Customer Excellence
86,605
$720.55K
−11.0%
SEVERINO MICHAEL
Director
85,821
$714.03K
+97.5%
Massaro Joseph R
Director
77,408
$644.03K
+187.4%
Murthy Mala
Director
69,479
$578.07K
+156.3%
Andres Juan
Director
65,480
$544.79K
+35.3%
Dingemans Simon
Director
56,495
$470.04K
Kang Lan
Director
52,315
$435.26K
+73.1%
Makin Louise
Director
47,140
$392.20K
Carethers John
Director
45,858
$381.54K
+59.5%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 23 May 2019